Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox vs Saline for Trigeminal Neuralgia
NCT06216886Phase 4Recruiting
- Sponsor
- Stanford University
- Start
- Jun 2024
- Primary completion
- Feb 2027
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of botulinum toxin type A in trigeminal neuralgia (TN), sponsored by Stanford University. Started Jun 2024; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
trigeminal neuralgia (TN)
Beyond the preview
Go deeper on NCT06216886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06216886.